{"id":"W2955546107","doi":"10.1158/1538-7445.am2019-ct025","title":"Abstract CT025: Phase Ib study of adavosertib in combination with olaparib in patients with refractory solid tumors: Dose escalation","year":2019,"lang":"en","type":"article","venue":"Cancer Research","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Olaparib; Neutropenia; Tolerability; Internal medicine; Nausea; Gastroenterology; Anemia; Vomiting; Toxicity; Refractory (planetary science); Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006921574,0.0009983977,0.001441623,0.0004916909,0.0003668851,0.000919672,0.0006624998,0.0007503644,0.004773333],"category_scores_gemma":[0.0005520057,0.0003411786,0.0008447884,0.0007693879,0.0005598197,0.0004886844,0.0002887694,0.002223899,0.001042294],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001011418,"about_ca_system_score_gemma":0.00170311,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001734295,"about_ca_topic_score_gemma":0.002431127,"domain_scores_codex":[0.9997717,0.00008881387,0.00002038906,0.00003949294,0.00003133485,0.00004834007],"domain_scores_gemma":[0.9996656,0.0000454844,0.00005590027,0.00002439174,0.00002653436,0.0001820266],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5800384,0.07019223,0.01284629,0.001609455,0.001663934,0.000914734,0.0003934413,0.007308613,0.1431796,0.0007712803,0.01140877,0.1696732],"study_design_scores_gemma":[0.4412857,0.5149091,0.01655327,0.00009444029,0.0005737817,0.0008949169,0.00009223613,0.003113982,0.01449141,0.0003064027,0.007638965,0.0000457564],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9884934,0.0018913,0.0005540063,0.0003502976,0.00008758249,0.002754444,0.002043445,0.0001205722,0.003704959],"genre_scores_gemma":[0.9876018,0.001149115,0.001544711,0.0006181205,0.00009275093,0.002102643,0.003973826,0.00002857342,0.002888395],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004773333,"threshold_uncertainty_score":0.01596832,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05630158811064657,"score_gpt":0.4262352520521331,"score_spread":0.3699336639414865,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}